Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02455882 · ClinicalTrials.gov registry record
Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer
A clinical trial, sponsored by University of Michigan.
- Terminated
- Registry status
- 14
- Enrollment target
NCT02455882 is a clinical trial that was terminated before completion, run by University of Michigan. The registered enrollment target is 14 participants.
The verdict
NCT02455882 was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
Through the investigators' Breast Care Center at the University of Michigan Comprehensive Cancer Center, the investigators treat approximately 75 patients per year with neoadjuvant chemotherapy. The majority of the remainder of patients with stage II and III disease undergo treatment with adjuvant chemotherapy either on a clinical protocol or as standard of care. There is a subset of women with ER positive disease who do not receive chemotherapy because of favorable tumor characteristics. This tissue procurement protocol is designed to systematically collect tissue, urine and blood specimens on patients undergoing neoadjuvant systemic therapy or adjuvant chemotherapy, serially following treatment, and/or at the time of disease recurrence in order to investigate mechanisms underlying development of metastatic disease, to identify predictors of response and resistance to therapy, and to test potential new therapies for breast cancer using a combination of patient-derived xenograft creation and new microfluidic technologies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2014-05-30 |
| Est. Completion | 2017-04-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02455882
The ClinicalTrials.gov registry entry for NCT02455882 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02455882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02455882 about?
NCT02455882 is a clinical study titled "Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer". Through the investigators' Breast Care Center at the University of Michigan Comprehensive Cancer Center, the investigators treat approximately 75 patients per year with neoadjuvant chemotherapy. The majority of the remainder of patients with stage II and III disease undergo treatment with adjuvant c...
What is the current status of trial NCT02455882?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2014-05-30. Estimated completion is 2017-04-07.
Who is sponsoring clinical trial NCT02455882?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.